10 years is so short for the universe, but is definitely a miracle for Thousand Oaks - from the establishment of the company to becoming a leader in the serum-free cell culture medium and macromolecular CDMO industry, by courtesy of trust from customers, support from society，and unremitting efforts made by all our staff members.
Since its establishment, Thousand Oaks has increased its staff strength from 30 to 500, completed a total of 1 billion yuan of financing, and provided thousands of media and CMC services for more than 100 customers at home and abroad. At present, Thousand Oaks has established technology development platforms for culture medium, cell line, upstream / downstream process, formulation, analysis, etc., and can carry out the production of culture medium, drug substance (DS), and drug product (DP) under cGMP conditions. It has an annual production capacity of 100,000 liters for DS and the world's largest annual production capacity of 1000 tons for dry powder culture medium. By integrating its advantages in cell line development, upstream / downstream process development, core raw material production and modular production technology, Thousand Oaks has formed an integrated cost control strategy which is unique in the industry, enabling customers to achieve the best cost efficiency of their product quality.
Since the 21st century, with rapid development of biopharmaceutical industry, the trend of division of labor based on specialization is irreversible and increasingly obvious. In an era when humanity keeps pursuing high-quality life and biopharmaceutical technologies gain continual progress, Thousand Oaks will continue to strengthen the expansion of capability and production capacity, serve customers better through continuous innovation, and push ahead with clinical and marketing progress for every innovative product quickly, so that they can benefit patients as soon as possible.
Thousand Oaks is committed to becoming the world's first-class provider of integrated solutions for large-scale production of biopharmaceuticals on a compliant basis (CMC). It fully understands life, reveres life, and always respects life. Together with its partners, Thousand Oaks provides patients around the world with more accessible and affordable high-quality drugs to safeguard human health.
Founder, Chairman and President of Thousand Oaks biopharmaceuticals